Inventor · disambiguated record
Oleg Belyaev
Also filed as: BELYAEV OLEG
10 granted patents·1 pending application·13 citations·filing 2011–2024
83Inventor score
Top patents by PatentIndex Score
11 records- 0187US2024376459A1Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0276US9328338B2Method for removing a lytic enzyme from a heterogeneous mixtureMEIDLER ROBERTO·Filed 2012·Granted May 3, 2016·5 cites·15 claims
- 0375US8603541B2Viral inactivated platelet extract, use and preparation thereofWEISSMAN LIOR·Filed 2011·Granted Dec 10, 2013·5 cites·14 claims
- 0473US11993797B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 0569US11225652B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Jan 18, 2022·0 cites·12 claims
- 0669US9023994B2Immunoglobulin reduced in thrombogenic agents and preparation thereofMINTZ RONI·Filed 2012·Granted May 5, 2015·2 cites·14 claims
- 0768US9943546B2Viral inactivated platelet extract, use and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Apr 17, 2018·1 cites·11 claims
- 0865US9212357B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 0964US10479987B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Nov 19, 2019·0 cites·9 claims
- 1045US9796770B2Immunoglobulin reduced in thrombogenic agents and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Oct 24, 2017·0 cites·22 claims
- 1136US10806755B2Plasma-supplemented formulationOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Oct 20, 2020·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →